BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29654063)

  • 1. A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition.
    Trenner A; Godau J; Sartori AA
    Mol Cancer Ther; 2018 Jul; 17(7):1392-1404. PubMed ID: 29654063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-stranded DNA binding function of RAD51 in DNA protection and its regulation by BRCA2.
    Halder S; Sanchez A; Ranjha L; Reginato G; Ceppi I; Acharya A; Anand R; Cejka P
    Mol Cell; 2022 Oct; 82(19):3553-3565.e5. PubMed ID: 36070766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
    Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
    Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery.
    Jiang J; Lu Y; Li Z; Li L; Niu D; Xu W; Liu J; Fu L; Zhou Z; Gu Y; Xia F
    Invest New Drugs; 2017 Jun; 35(3):251-259. PubMed ID: 28111726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination.
    Schipani F; Manerba M; Marotta R; Poppi L; Gennari A; Rinaldi F; Armirotti A; Farabegoli F; Roberti M; Di Stefano G; Rocchia W; Girotto S; Tirelli N; Cavalli A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RADX Promotes Genome Stability and Modulates Chemosensitivity by Regulating RAD51 at Replication Forks.
    Dungrawala H; Bhat KP; Le Meur R; Chazin WJ; Ding X; Sharan SK; Wessel SR; Sathe AA; Zhao R; Cortez D
    Mol Cell; 2017 Aug; 67(3):374-386.e5. PubMed ID: 28735897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RADX Modulates RAD51 Activity to Control Replication Fork Protection.
    Bhat KP; Krishnamoorthy A; Dungrawala H; Garcin EB; Modesti M; Cortez D
    Cell Rep; 2018 Jul; 24(3):538-545. PubMed ID: 30021152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication fork reversal triggers fork degradation in BRCA2-defective cells.
    Mijic S; Zellweger R; Chappidi N; Berti M; Jacobs K; Mutreja K; Ursich S; Ray Chaudhuri A; Nussenzweig A; Janscak P; Lopes M
    Nat Commun; 2017 Oct; 8(1):859. PubMed ID: 29038466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments.
    Kolinjivadi AM; Sannino V; De Antoni A; Zadorozhny K; Kilkenny M; Técher H; Baldi G; Shen R; Ciccia A; Pellegrini L; Krejci L; Costanzo V
    Mol Cell; 2017 Sep; 67(5):867-881.e7. PubMed ID: 28757209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of filament formation of human Rad51 protein by a small peptide derived from the BRC-motif of the BRCA2 protein.
    Nomme J; Takizawa Y; Martinez SF; Renodon-Cornière A; Fleury F; Weigel P; Yamamoto K; Kurumizaka H; Takahashi M
    Genes Cells; 2008 May; 13(5):471-81. PubMed ID: 18429819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication fork stability confers chemoresistance in BRCA-deficient cells.
    Ray Chaudhuri A; Callen E; Ding X; Gogola E; Duarte AA; Lee JE; Wong N; Lafarga V; Calvo JA; Panzarino NJ; John S; Day A; Crespo AV; Shen B; Starnes LM; de Ruiter JR; Daniel JA; Konstantinopoulos PA; Cortez D; Cantor SB; Fernandez-Capetillo O; Ge K; Jonkers J; Rottenberg S; Sharan SK; Nussenzweig A
    Nature; 2016 Jul; 535(7612):382-7. PubMed ID: 27443740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
    Kim TM; Son MY; Dodds S; Hu L; Hasty P
    Mutat Res; 2014; 766-767():66-72. PubMed ID: 25847274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservation.
    Kwon Y; Rösner H; Zhao W; Selemenakis P; He Z; Kawale AS; Katz JN; Rogers CM; Neal FE; Badamchi Shabestari A; Petrosius V; Singh AK; Joel MZ; Lu L; Holloway SP; Burma S; Mukherjee B; Hromas R; Mazin A; Wiese C; Sørensen CS; Sung P
    Nat Commun; 2023 Jan; 14(1):432. PubMed ID: 36702902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of BRC4 induced by a Tet-On 3G system suppress DNA repair and impair cell proliferation in vertebrate cells.
    Abe T; Branzei D
    DNA Repair (Amst); 2014 Oct; 22():153-64. PubMed ID: 25218467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51.
    Carreira A; Hilario J; Amitani I; Baskin RJ; Shivji MK; Venkitaraman AR; Kowalczykowski SC
    Cell; 2009 Mar; 136(6):1032-43. PubMed ID: 19303847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells.
    Roberti M; Schipani F; Bagnolini G; Milano D; Giacomini E; Falchi F; Balboni A; Manerba M; Farabegoli F; De Franco F; Robertson J; Minucci S; Pallavicini I; Di Stefano G; Girotto S; Pellicciari R; Cavalli A
    Eur J Med Chem; 2019 Mar; 165():80-92. PubMed ID: 30660828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preomic profile of BxPC-3 cells after treatment with BRC4.
    Previtali V; Myers SH; Poppi L; Wynne K; Casamassima I; Girotto S; Di Stefano G; Farabegoli F; Roberti M; Oliviero G; Cavalli A
    J Proteomics; 2023 Sep; 288():104983. PubMed ID: 37536521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated mutations in BRC domains of BRCA2 affect homologous recombination induced by Rad51.
    Tal A; Arbel-Goren R; Stavans J
    J Mol Biol; 2009 Nov; 393(5):1007-12. PubMed ID: 19747923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib.
    Bagnolini G; Milano D; Manerba M; Schipani F; Ortega JA; Gioia D; Falchi F; Balboni A; Farabegoli F; De Franco F; Robertson J; Pellicciari R; Pallavicini I; Peri S; Minucci S; Girotto S; Di Stefano G; Roberti M; Cavalli A
    J Med Chem; 2020 Mar; 63(5):2588-2619. PubMed ID: 32037829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
    Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
    Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.